J Clin Virol. 2008 Mar;41(3):224-30. Epub 2007 Dec 3.

Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.

Source

Division of Pediatric Infectious Diseases and Immunology, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, 2001 6th Street SE, Minneapolis, MN 55455, USA. schleiss@umn.edu

Abstract

Vaccines are urgently needed to protect newborns against the devastating sequelae of congenital cytomegalovirus infection. Evaluation of candidate vaccines in the guinea pig model of congenital infection can shed light on potentially useful strategies for humans, since guinea pig CMV (GPCMV) is transmitted to the fetus transplacentally, causing infection and disease in utero. A number of vaccine strategies have been evaluated in this model, including DNA vaccines, live attenuated vaccines, and recombinant glycoprotein vaccines. Induction of virus-neutralizing antibody appears to play a key role in protection of the fetus. Recently, a vectored vaccine based on the GPCMV homolog of the UL83 (pp65) protein has also been shown to be effective when used as a preconceptual vaccine in this model, suggesting that strategies designed to elicit T-cell responses may be of value in protection of the fetus.

PMID:: 18060834; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Cytomegalovirus Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83. [Viral Immunol. 2000]
Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR, Bourne N, Jensen NJ, Bravo F, Bernstein DI. Viral Immunol. 2000; 13(2):155-67.
Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. [J Infect Dis. 2003]
Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
Schleiss MR, Bourne N, Bernstein DI. J Infect Dis. 2003 Dec 15; 188(12):1868-74. Epub 2003 Dec 9.
Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. [J Infect Dis. 2007]
Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
Schleiss MR, Lacayo JC, Belkaid Y, McGregor A, Stroup G, Rayner J, Alterson K, Chulay JD, Smith JF. J Infect Dis. 2007 Mar 15; 195(6):789-98. Epub 2007 Feb 6.
Review Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV). [J Clin Virol. 2002]
Review Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).
Schleiss MR. J Clin Virol. 2002 Aug; 25 Suppl 2:S37-49.
Review Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. [ILAR J. 2006]
Review Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns.
Schleiss MR. ILAR J. 2006; 47(1):65-72.

See reviews... See all...

Cited by 5 PubMed Central articles

Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. [J Clin Invest. 2010]
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Slavuljica I, Busche A, Babić M, Mitrović M, Gašparović I, Cekinović D, Markova Car E, Pernjak Pugel E, Ciković A, Lisnić VJ, et al. J Clin Invest. 2010 Dec; 120(12):4532-45. Epub 2010 Nov 22.
Prevention of maternal cytomegalovirus infection: current status and future prospects. [Int J Womens Health. 2010]
Prevention of maternal cytomegalovirus infection: current status and future prospects.
Nyholm JL, Schleiss MR. Int J Womens Health. 2010 Aug 9; 2:23-35. Epub 2010 Aug 9.
Review Herpesvirus BACs: past, present, and future. [J Biomed Biotechnol. 2011]
Review Herpesvirus BACs: past, present, and future.
Warden C, Tang Q, Zhu H. J Biomed Biotechnol. 2011; 2011:124595. Epub 2010 Oct 27.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Comparison of vaccine strategies against congenital CMV infection in the guinea ...
Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
J Clin Virol. 2008 Mar ;41(3):224-30. Epub 2007 Dec 3 .

PubMed
Analysis of factors related to truncal decompensation following Cotrel-Dubousset...
Analysis of factors related to truncal decompensation following Cotrel-Dubousset instrumentation.
J Spinal Disord. 1991 Jun ;4(2):188-92.

PubMed
Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's ...
Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease.
Int J Biochem Cell Biol. 2008 ;40(4):731-46. Epub 2007 Oct 22 .

PubMed
Cell-cycle progression without an intact microtuble cytoskeleton.
Cell-cycle progression without an intact microtuble cytoskeleton.
Curr Biol. 2007 Dec 4 ;17(23):2081-6.

PubMed
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia ...
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Respir Med. 2008 Mar ;102(3):407-12. Epub 2007 Dec 3 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: